Leukocyte response is regulated by microRNA let7i in patients with acute ischemic stroke

Glen C. Jickling, Bradley Ander, Natasha Shroff, Miles Orantia, Boryana Stamova, Cheryl Dykstra-Aiello, Heather Hull, Xinhua Zhan, Da Liu, Frank R Sharp

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: To evaluate microRNA let7i in ischemic stroke and its regulation of leukocytes. Methods: A total of 212 patients were studied: 106 with acute ischemic stroke and 106 controls matched for risk factors. RNA from circulating leukocytes was isolated from blood collected in PAXgene tubes. Let7i microRNA expression was assessed using TaqMan quantitative reverse transcription PCR. To assess let7i regulation of gene expression in stroke, messenger RNA (mRNA) from leukocytes was measured by whole-genome Human Transcriptome Array Affymetrix microarray. Given microRNAs act to destabilize and degrade their target mRNA, mRNAs that inversely correlated with let7i were identified. To demonstrate let7i posttranscriptional regulation of target genes, a 3′ untranslated region luciferase assay was performed. Target protein expression was assessed using ELISA. Results: Let7i was decreased in patients with acute ischemic stroke (fold change -1.70, p < 0.00001). A modest inverse correlation between let7i and NIH Stroke Scale score at admission (r -0.32, p 0.02), infarct volume (r -0.21, p 0.04), and plasma MMP9 (r -0.46, p 0.01) was identified. The decrease in let7i was associated with increased expression of several of its mRNA targets, including CD86, CXCL8, and HMGB1. In vitro studies confirm let7i posttranscriptional regulation of target genes CD86, CXCL8, and HMGB1. Functional analysis predicted let7i regulates pathways involved in leukocyte activation, recruitment, and proliferation including canonical pathways of CD86 signaling in T helper cells, HMGB1 signaling, and CXCL8 signaling. Conclusions: Let7i is decreased in circulating leukocytes of patients with acute ischemic stroke. Mechanisms by which let7i regulates inflammatory response post stroke include targeting CD86, CXCL8, and HMGB1.

Original languageEnglish (US)
Pages (from-to)2198-2205
Number of pages8
JournalNeurology
Volume87
Issue number21
DOIs
StatePublished - Nov 22 2016

Fingerprint

MicroRNAs
Leukocytes
HMGB1 Protein
Stroke
Messenger RNA
Gene Expression Regulation
3' Untranslated Regions
Human Genome
Helper-Inducer T-Lymphocytes
Luciferases
Transcriptome
Genes
Reverse Transcription
Enzyme-Linked Immunosorbent Assay
RNA
Polymerase Chain Reaction
Proteins

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Leukocyte response is regulated by microRNA let7i in patients with acute ischemic stroke. / Jickling, Glen C.; Ander, Bradley; Shroff, Natasha; Orantia, Miles; Stamova, Boryana; Dykstra-Aiello, Cheryl; Hull, Heather; Zhan, Xinhua; Liu, Da; Sharp, Frank R.

In: Neurology, Vol. 87, No. 21, 22.11.2016, p. 2198-2205.

Research output: Contribution to journalArticle

Jickling, Glen C. ; Ander, Bradley ; Shroff, Natasha ; Orantia, Miles ; Stamova, Boryana ; Dykstra-Aiello, Cheryl ; Hull, Heather ; Zhan, Xinhua ; Liu, Da ; Sharp, Frank R. / Leukocyte response is regulated by microRNA let7i in patients with acute ischemic stroke. In: Neurology. 2016 ; Vol. 87, No. 21. pp. 2198-2205.
@article{ad598d08c93e44b78baf74418d689d4f,
title = "Leukocyte response is regulated by microRNA let7i in patients with acute ischemic stroke",
abstract = "Objective: To evaluate microRNA let7i in ischemic stroke and its regulation of leukocytes. Methods: A total of 212 patients were studied: 106 with acute ischemic stroke and 106 controls matched for risk factors. RNA from circulating leukocytes was isolated from blood collected in PAXgene tubes. Let7i microRNA expression was assessed using TaqMan quantitative reverse transcription PCR. To assess let7i regulation of gene expression in stroke, messenger RNA (mRNA) from leukocytes was measured by whole-genome Human Transcriptome Array Affymetrix microarray. Given microRNAs act to destabilize and degrade their target mRNA, mRNAs that inversely correlated with let7i were identified. To demonstrate let7i posttranscriptional regulation of target genes, a 3′ untranslated region luciferase assay was performed. Target protein expression was assessed using ELISA. Results: Let7i was decreased in patients with acute ischemic stroke (fold change -1.70, p < 0.00001). A modest inverse correlation between let7i and NIH Stroke Scale score at admission (r -0.32, p 0.02), infarct volume (r -0.21, p 0.04), and plasma MMP9 (r -0.46, p 0.01) was identified. The decrease in let7i was associated with increased expression of several of its mRNA targets, including CD86, CXCL8, and HMGB1. In vitro studies confirm let7i posttranscriptional regulation of target genes CD86, CXCL8, and HMGB1. Functional analysis predicted let7i regulates pathways involved in leukocyte activation, recruitment, and proliferation including canonical pathways of CD86 signaling in T helper cells, HMGB1 signaling, and CXCL8 signaling. Conclusions: Let7i is decreased in circulating leukocytes of patients with acute ischemic stroke. Mechanisms by which let7i regulates inflammatory response post stroke include targeting CD86, CXCL8, and HMGB1.",
author = "Jickling, {Glen C.} and Bradley Ander and Natasha Shroff and Miles Orantia and Boryana Stamova and Cheryl Dykstra-Aiello and Heather Hull and Xinhua Zhan and Da Liu and Sharp, {Frank R}",
year = "2016",
month = "11",
day = "22",
doi = "10.1212/WNL.0000000000003354",
language = "English (US)",
volume = "87",
pages = "2198--2205",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "21",

}

TY - JOUR

T1 - Leukocyte response is regulated by microRNA let7i in patients with acute ischemic stroke

AU - Jickling, Glen C.

AU - Ander, Bradley

AU - Shroff, Natasha

AU - Orantia, Miles

AU - Stamova, Boryana

AU - Dykstra-Aiello, Cheryl

AU - Hull, Heather

AU - Zhan, Xinhua

AU - Liu, Da

AU - Sharp, Frank R

PY - 2016/11/22

Y1 - 2016/11/22

N2 - Objective: To evaluate microRNA let7i in ischemic stroke and its regulation of leukocytes. Methods: A total of 212 patients were studied: 106 with acute ischemic stroke and 106 controls matched for risk factors. RNA from circulating leukocytes was isolated from blood collected in PAXgene tubes. Let7i microRNA expression was assessed using TaqMan quantitative reverse transcription PCR. To assess let7i regulation of gene expression in stroke, messenger RNA (mRNA) from leukocytes was measured by whole-genome Human Transcriptome Array Affymetrix microarray. Given microRNAs act to destabilize and degrade their target mRNA, mRNAs that inversely correlated with let7i were identified. To demonstrate let7i posttranscriptional regulation of target genes, a 3′ untranslated region luciferase assay was performed. Target protein expression was assessed using ELISA. Results: Let7i was decreased in patients with acute ischemic stroke (fold change -1.70, p < 0.00001). A modest inverse correlation between let7i and NIH Stroke Scale score at admission (r -0.32, p 0.02), infarct volume (r -0.21, p 0.04), and plasma MMP9 (r -0.46, p 0.01) was identified. The decrease in let7i was associated with increased expression of several of its mRNA targets, including CD86, CXCL8, and HMGB1. In vitro studies confirm let7i posttranscriptional regulation of target genes CD86, CXCL8, and HMGB1. Functional analysis predicted let7i regulates pathways involved in leukocyte activation, recruitment, and proliferation including canonical pathways of CD86 signaling in T helper cells, HMGB1 signaling, and CXCL8 signaling. Conclusions: Let7i is decreased in circulating leukocytes of patients with acute ischemic stroke. Mechanisms by which let7i regulates inflammatory response post stroke include targeting CD86, CXCL8, and HMGB1.

AB - Objective: To evaluate microRNA let7i in ischemic stroke and its regulation of leukocytes. Methods: A total of 212 patients were studied: 106 with acute ischemic stroke and 106 controls matched for risk factors. RNA from circulating leukocytes was isolated from blood collected in PAXgene tubes. Let7i microRNA expression was assessed using TaqMan quantitative reverse transcription PCR. To assess let7i regulation of gene expression in stroke, messenger RNA (mRNA) from leukocytes was measured by whole-genome Human Transcriptome Array Affymetrix microarray. Given microRNAs act to destabilize and degrade their target mRNA, mRNAs that inversely correlated with let7i were identified. To demonstrate let7i posttranscriptional regulation of target genes, a 3′ untranslated region luciferase assay was performed. Target protein expression was assessed using ELISA. Results: Let7i was decreased in patients with acute ischemic stroke (fold change -1.70, p < 0.00001). A modest inverse correlation between let7i and NIH Stroke Scale score at admission (r -0.32, p 0.02), infarct volume (r -0.21, p 0.04), and plasma MMP9 (r -0.46, p 0.01) was identified. The decrease in let7i was associated with increased expression of several of its mRNA targets, including CD86, CXCL8, and HMGB1. In vitro studies confirm let7i posttranscriptional regulation of target genes CD86, CXCL8, and HMGB1. Functional analysis predicted let7i regulates pathways involved in leukocyte activation, recruitment, and proliferation including canonical pathways of CD86 signaling in T helper cells, HMGB1 signaling, and CXCL8 signaling. Conclusions: Let7i is decreased in circulating leukocytes of patients with acute ischemic stroke. Mechanisms by which let7i regulates inflammatory response post stroke include targeting CD86, CXCL8, and HMGB1.

UR - http://www.scopus.com/inward/record.url?scp=84996537849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996537849&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000003354

DO - 10.1212/WNL.0000000000003354

M3 - Article

C2 - 27784773

AN - SCOPUS:84996537849

VL - 87

SP - 2198

EP - 2205

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 21

ER -